Evaluation of Reference variability [Design Issues]

posted by Nirali  – India, 2009-04-17 09:38 (5910 d 03:06 ago) – Posting: # 3551
Views: 4,264

Thank you friends.

Actually, we got the proposal to evaluate reference variability using below design:
"2-period replicate design to assess the intra-subject variability of reference drug, in which reference drug given in both the periods".

Shall it be appropriate design to evaluate reference variability for EU regulatory? :confused:

Regards,
NIRALI

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,673 registered users;
48 visitors (0 registered, 48 guests [including 8 identified bots]).
Forum time: 12:45 CEST (Europe/Vienna)

Medical researches can be divided into two sorts:
those who think that meta is better and those
who believe that pooling is fooling.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5